Literature DB >> 3024378

Monoclonal antibodies. Clinical uses and potential.

P B Carter, K H Beegle, D H Gebhard.   

Abstract

An overview of monoclonal antibody technology and some examples of its relevance to veterinary medicine are presented in this article. A technical description of the generation of immune spleen cells and hybridization is included. Feline leukemia, canine parvovirus, and their respective diseases are included as examples of cases in which monoclonal antibodies can be applied in the diagnosis and characterization of these diseases and their etiologic agent.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3024378     DOI： 10.1016/s0195-5616(86)50135-2

Source DB:  PubMed          Journal:  Vet Clin North Am Small Anim Pract        ISSN： 0195-5616            Impact factor:   2.093


  4 in total

1.  The crystal structure of the active domain of Anopheles anti-platelet protein, a powerful anti-coagulant, in complex with an antibody.

Authors:  Kanako Sugiyama; Mitsuhiro Iyori; Asuka Sawaguchi; Satoko Akashi; Jeremy R H Tame; Sam-Yong Park; Shigeto Yoshida
Journal:  J Biol Chem       Date:  2014-04-24       Impact factor: 5.157

2.  Identification and expression of a Mycoplasma gallisepticum surface antigen recognized by a monoclonal antibody capable of inhibiting both growth and metabolism.

Authors:  S Yoshida; A Fujisawa; Y Tsuzaki; S Saitoh
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

3.  URF13, a maize mitochondrial pore-forming protein, is oligomeric and has a mixed orientation in Escherichia coli plasma membranes.

Authors:  K L Korth; C I Kaspi; J N Siedow; C S Levings
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

4.  In Silico Generation of Peptides by Replica Exchange Monte Carlo: Docking-Based Optimization of Maltose-Binding-Protein Ligands.

Authors:  Anna Russo; Pasqualina Liana Scognamiglio; Rolando Pablo Hong Enriquez; Carlo Santambrogio; Rita Grandori; Daniela Marasco; Antonio Giordano; Giacinto Scoles; Sara Fortuna
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.